news study rov

For patients with colorectal cancer that has metastasized to the liver, having a primary tumor on the left side, as opposed to the right side of the colon, is known to be a significant advantage in terms of treatment response.

But now a new study, presented here at the ESMO 19th World Congress on Gastrointestinal Cancer, suggests this imbalance may be at least partially
redressed.

Reversing the usual pattern, patients whose liver metastases had spread from rightsided primary tumors (RSP) had a 36% better survival rate after treatment with a combination of firstline chemotherapy and selective internal radiation therapy (SIRT) using Y90 resin microspheres, compared to chemotherapy alone, according to the study.

Click here to read more

Follow us on Facebook

Genesis Logo Small.pngGenesisCare is Australia’s leading provider of radiation oncology, cardiology and sleep treatments. We exist to fill the treatment gap for the biggest disease burdens in Australia - cancer and heart care - in an environment of substantial unmet demand from an ageing population. Click here to learn more